Hong-Tao Wang

891 total citations
54 papers, 675 citations indexed

About

Hong-Tao Wang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hong-Tao Wang has authored 54 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Immunology. Recurrent topics in Hong-Tao Wang's work include Immunotherapy and Immune Responses (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Myeloid Leukemia Research (4 papers). Hong-Tao Wang is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Myeloid Leukemia Research (4 papers). Hong-Tao Wang collaborates with scholars based in China, United States and South Korea. Hong-Tao Wang's co-authors include Dahai Hu, Zhao Zheng, Shichao Han, Hao Guan, Zhuogang Liu, Tao Ke, Linlin Su, Yu Chen, Huayu Zhu and Yu‐Lin Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Hong-Tao Wang

51 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong-Tao Wang China 14 218 124 107 95 80 54 675
Guanyu Jiang China 13 264 1.2× 160 1.3× 175 1.6× 142 1.5× 33 0.4× 37 828
Giuseppe Scavone Italy 12 233 1.1× 101 0.8× 35 0.3× 65 0.7× 18 0.2× 18 597
Takeshi Ueha Japan 15 205 0.9× 141 1.1× 149 1.4× 21 0.2× 10 0.1× 37 663
Kyung Hee Hong South Korea 10 211 1.0× 101 0.8× 67 0.6× 156 1.6× 6 0.1× 27 690
Christine Herzog Germany 16 292 1.3× 115 0.9× 115 1.1× 75 0.8× 12 0.1× 33 892
Bo Jia China 13 123 0.6× 98 0.8× 48 0.4× 96 1.0× 7 0.1× 40 541
Augustin Latourte France 15 363 1.7× 218 1.8× 114 1.1× 80 0.8× 10 0.1× 52 1.2k
Paulo Sérgio Martins de Alcântara Brazil 16 361 1.7× 101 0.8× 123 1.1× 61 0.6× 25 0.3× 30 916
Stephen M. Twigg Australia 9 394 1.8× 78 0.6× 44 0.4× 48 0.5× 13 0.2× 10 704
Lin Yin China 16 410 1.9× 172 1.4× 77 0.7× 47 0.5× 23 0.3× 57 953

Countries citing papers authored by Hong-Tao Wang

Since Specialization
Citations

This map shows the geographic impact of Hong-Tao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong-Tao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong-Tao Wang more than expected).

Fields of papers citing papers by Hong-Tao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong-Tao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong-Tao Wang. The network helps show where Hong-Tao Wang may publish in the future.

Co-authorship network of co-authors of Hong-Tao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hong-Tao Wang. A scholar is included among the top collaborators of Hong-Tao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong-Tao Wang. Hong-Tao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jining, et al.. (2024). Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML. Annals of Hematology. 103(10). 3855–3866. 1 indexed citations
2.
Dong, Jinyan, et al.. (2024). Acute lung injury: a view from the perspective of necroptosis. Inflammation Research. 73(6). 997–1018. 9 indexed citations
3.
Fu, Shuang, Mengqi Li, & Hong-Tao Wang. (2023). BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report. Frontiers in Pharmacology. 14. 1141311–1141311.
5.
Olaleye, Olajide E., Wei Yang, Feifei Du, et al.. (2021). Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule. Acta Pharmacologica Sinica. 42(12). 2155–2172. 27 indexed citations
6.
Yang, Ying, Zhuogang Liu, Hong-Tao Wang, & Guojun Zhang. (2021). HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple Myeloma. Frontiers in Oncology. 11. 670673–670673. 8 indexed citations
7.
Wu, Li, et al.. (2020). Development and verification of a personalized immune prognostic feature in breast cancer. Experimental Biology and Medicine. 245(14). 1242–1253. 1 indexed citations
8.
Wang, Hong-Tao, et al.. (2020). FBN1 promotes DLBCL cell migration by activating the Wnt/β-catenin signaling pathway and regulating TIMP1.. American Journal of Translational Research. 12(11). 7340–7353. 9 indexed citations
9.
Zhang, Guojun, et al.. (2019). Investigation of candidate molecular biomarkers for expression profile analysis of the Gene expression omnibus (GEO) in acute lymphocytic leukemia (ALL). Biomedicine & Pharmacotherapy. 120. 109530–109530. 14 indexed citations
10.
Tijaro-Ovalle, Natalia M., Theodoros Karantanos, Hong-Tao Wang, & Vassiliki A. Boussiotis. (2019). Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease. Frontiers in Immunology. 10. 295–295. 18 indexed citations
11.
Zhu, Qingqing, Yuanyuan Wang, Yang Lü, et al.. (2018). The role and clinical significance of programmed cell death- ligand 1 expressed on CD19+B-cells and subsets in systemic lupus erythematosus. Clinical Immunology. 198. 89–99. 14 indexed citations
12.
Zhu, Huayu, Wendong Bai, Chao Li, et al.. (2016). Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts. Scientific Reports. 6(1). 24728–24728. 62 indexed citations
13.
Chang, Ying‐Jun, Hong-Tao Wang, Lan‐Ping Xu, et al.. (2016). Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantation. Leukemia & lymphoma. 57(9). 2133–2139. 9 indexed citations
14.
Zeng, Di, Yan Jin, Xiongtao Liu, et al.. (2013). The Long-Term Differentiation of Embryonic Stem Cells into Cardiomyocytes: An Indirect Co-Culture Model. PLoS ONE. 8(1). e55233–e55233. 13 indexed citations
15.
Shi, Jihong, Dahai Hu, Zhanfeng Zhang, et al.. (2012). Reduced expression of microtubule-associated protein 1 light chain 3 in hypertrophic scars. Archives of Dermatological Research. 304(3). 209–215. 31 indexed citations
16.
Zhang, Zhanfeng, Dahai Hu, Jihong Shi, et al.. (2011). Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. Burns. 37(4). 665–672. 32 indexed citations
17.
Chen, Lei, Hong-Tao Wang, Xiaohua Han, et al.. (2008). Behavioral and electrophysiological effects of pallidal GABAB receptor activation and blockade on haloperidol-induced akinesia in rats. Brain Research. 1244. 65–70. 7 indexed citations
18.
Wang, Hong-Tao. (2005). Effect ofHelicobacter pyloriVacA on gene expression of gastric cancer cells. World Journal of Gastroenterology. 11(1). 109–109. 7 indexed citations
19.
Feng, Zuo‐Hua, Bo Huang, Guimei Zhang, Dong Li, & Hong-Tao Wang. (2003). Inducement of antitumor-immunity by DC activated by Hsp70-H22 tumor antigen peptide. Chinese Journal of Cancer Research. 15(2). 79–85. 2 indexed citations
20.
Wang, Hong-Tao, et al.. (2002). [Experimental studies on the anti-thrombosis effect of 3,4-oxo-isopropylidene-shikimic acid].. PubMed. 37(4). 245–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026